The Sortina´s mission is to create a platform of life-saving 
world-class small molecule therapeutics targeting sortilin.
Focusing on critical diseases such as cancer and 
neurodegenerative conditions where sortilin overexpression 
or dysfunction has been linked to disease progression.

In-house development of a first in class cancer drug, starting 
with Glioblastoma Multiforme, followed by consecutive 
inclusion of additional cancer forms and parallel optimization 
of unique small molecules for neurodegenerative diseases and beyond.

Sortina Pharma

Org chart

Teams

Offices